{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:50:08Z","timestamp":1788544208773,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04494-7","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T22:14:09Z","timestamp":1766528049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Celine","family":"Tack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Van den Houte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linde","family":"Besard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Capiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Ceulemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gernay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Raat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Stubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Van Boxstael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Vandeput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Van Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Gehesqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Raes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"4494_CR1","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M et al. Bowel Disorders Gastroenterol. 2016."},{"issue":"1","key":"4494_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","volume":"160","author":"AD Sperber","year":"2021","unstructured":"Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional Gastrointestinal Disorders, results of Rome foundation global study. Gastroenterology. 2021;160(1):99\u2013e1143.","journal-title":"Gastroenterology"},{"issue":"2","key":"4494_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/2050640618821804","volume":"7","author":"K Van den Houte","year":"2019","unstructured":"Van den Houte K, Carbone F, Pannemans J, Corsetti M, Fischler B, Piessevaux H, et al. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United Eur Gastroenterol J. 2019;7(2):307\u201315.","journal-title":"United Eur Gastroenterol J"},{"issue":"3","key":"4494_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5009\/gnl14344","volume":"9","author":"SM Bennet","year":"2015","unstructured":"Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9(3):318\u201331.","journal-title":"Gut Liver"},{"issue":"12","key":"4494_CR5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1111\/nmo.12475","volume":"26","author":"M Corsetti","year":"2014","unstructured":"Corsetti M, Van Oudenhove L, Tack J. The quest for biomarkers in IBS-where should it lead us? Neurogastroenterol Motil. 2014;26(12):1669\u201376.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"4494_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2468-1253(16)30023-1","volume":"1","author":"GJ Holtmann","year":"2016","unstructured":"Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1(2):133\u201346.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"33","key":"4494_CR7","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.3748\/wjg.v24.i33.3681","volume":"24","author":"MG Mumolo","year":"2018","unstructured":"Mumolo MG, Bertani L, Ceccarelli L, Laino G, Di Fluri G, Albano E, et al. From bench to bedside: fecal calprotectin in inflammatory bowel diseases clinical setting. World J Gastroenterol. 2018;24(33):3681\u201394.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"4494_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.crohns.2013.02.014","volume":"7","author":"G Rogler","year":"2013","unstructured":"Rogler G, Aldeguer X, Kruis W, Lasson A, Mittmann U, Nally K, et al. Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion. J Crohns Colitis. 2013;7(8):670\u20137.","journal-title":"J Crohns Colitis"},{"issue":"5","key":"4494_CR9","first-page":"425","volume":"32","author":"A Mari","year":"2019","unstructured":"Mari A, Baker FA, Mahamid M, Yacoob A, Sbeit W, Khoury T. Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician. Ann Gastroenterol. 2019;32(5):425\u201330.","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"4494_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ajg.2008.86","volume":"104","author":"J Langhorst","year":"2009","unstructured":"Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, et al. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome. Am J Gastroenterol. 2009;104(2):404\u201310.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"4494_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","volume":"7","author":"L Ohman","year":"2010","unstructured":"Ohman L, Simr\u00e9n M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7(3):163\u201373.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"4494_CR12","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/00365520802272126","volume":"43","author":"J Forshammar","year":"2008","unstructured":"Forshammar J, Isaksson S, Strid H, Stotzer PO, Sj\u00f6vall H, Simr\u00e9n M, et al. A pilot study of colonic B cell pattern in irritable bowel syndrome. Scand J Gastroenterol. 2008;43(12):1461\u20136.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"4494_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cgh.2009.09.032","volume":"8","author":"JS Leeds","year":"2010","unstructured":"Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, et al. Some patients with irritable bowel syndrome May have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol. 2010;8(5):433\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4494_CR14","doi-asserted-by":"crossref","unstructured":"Algera J, Colomier E, Simr\u00e9n M. The dietary management of patients with irritable bowel syndrome: A narrative review of the existing and emerging evidence. Nutrients. 2019;11(9):2162","DOI":"10.3390\/nu11092162"},{"issue":"6","key":"4494_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/2050640617731968","volume":"5","author":"P Moayyedi","year":"2017","unstructured":"Moayyedi P, Mearin F, Azpiroz F, Andresen V, Barbara G, Corsetti M, et al. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United Eur Gastroenterol J. 2017;5(6):773\u201388.","journal-title":"United Eur Gastroenterol J"},{"issue":"11","key":"4494_CR16","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1136\/gutjnl-2021-325821","volume":"71","author":"F Carbone","year":"2022","unstructured":"Carbone F, Van den Houte K, Besard L, Tack C, Arts J, Caenepeel P, et al. Diet or medication in primary care patients with IBS: the DOMINO study - a randomised trial supported by the Belgian health care knowledge centre (KCE trials Programme) and the Rome foundation research Institute. Gut. 2022;71(11):2226\u201332.","journal-title":"Gut"},{"key":"4494_CR17","doi-asserted-by":"crossref","unstructured":"Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP diet improves irritable bowel syndrome symptoms: A Meta-Analysis. Nutrients. 2017;9(9):940","DOI":"10.3390\/nu9090940"},{"key":"4494_CR18","doi-asserted-by":"crossref","unstructured":"Knauf GA, Cunningham AL, Kazi MI, Riddington IM, Crofts AA, Cattoir V et al. Exploring the antimicrobial action of quaternary amines against acinetobacter baumannii. mBio. 2018;9(1).","DOI":"10.1128\/mBio.02394-17"},{"key":"4494_CR19","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3389\/fmicb.2020.01720","volume":"11","author":"L Zhou","year":"2020","unstructured":"Zhou L, She P, Tan F, Li S, Zeng X, Chen L, et al. Repurposing antispasmodic agent Otilonium bromide for treatment of Staphylococcus aureus infections. Front Microbiol. 2020;11:1720.","journal-title":"Front Microbiol"},{"key":"4494_CR20","doi-asserted-by":"publisher","unstructured":"Tack J, Drossman DA. What\u2019s new in Rome IV? Neurogastroenterol Motil. 2017;29(9). https:\/\/doi.org\/10.1111\/nmo.13053","DOI":"10.1111\/nmo.13053"},{"issue":"2","key":"4494_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395\u2013402.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"4494_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1053\/j.gastro.2021.11.019","volume":"162","author":"DA Drossman","year":"2022","unstructured":"Drossman DA, Tack J. Rome foundation clinical diagnostic criteria for disorders of Gut-Brain interaction. Gastroenterology. 2022;162(3):675\u20139.","journal-title":"Gastroenterology"},{"issue":"22","key":"4494_CR23","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","volume":"282","author":"M Visser","year":"1999","unstructured":"Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-Reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131\u20135.","journal-title":"JAMA"},{"issue":"7","key":"4494_CR24","first-page":"411","volume":"10","author":"O Pickett-Blakely","year":"2014","unstructured":"Pickett-Blakely O. Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol (N Y). 2014;10(7):411\u20136.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"3","key":"4494_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/MCG.0000000000000327","volume":"50","author":"K Hod","year":"2016","unstructured":"Hod K, Ringel-Kulka T, Martin CF, Maharshak N, Ringel Y. High-sensitive C-Reactive protein as a marker for inflammation in irritable bowel syndrome. J Clin Gastroenterol. 2016;50(3):227\u201332.","journal-title":"J Clin Gastroenterol"},{"key":"4494_CR26","doi-asserted-by":"publisher","unstructured":"Hod K, Sperber AD, Ron Y, Boaz M, Dickman R, Berliner S et al. A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS. Neurogastroenterol Motil. 2017;29(7). https:\/\/doi.org\/10.1111\/nmo.13037","DOI":"10.1111\/nmo.13037"},{"issue":"5","key":"4494_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1053\/j.gastro.2013.01.049","volume":"144","author":"MI Vazquez-Roque","year":"2013","unstructured":"Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O\u2019Neill J, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(5):903\u201311. e3.","journal-title":"Gastroenterology"},{"issue":"7","key":"4494_CR28","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.3390\/nu13072469","volume":"13","author":"L Prospero","year":"2021","unstructured":"Prospero L, Riezzo G, Linsalata M, Orlando A, D\u2019Attoma B, Russo F. Psychological and Gastrointestinal symptoms of patients with irritable bowel syndrome undergoing a Low-FODMAP diet: the role of the intestinal barrier. Nutrients. 2021;13(7):2469.","journal-title":"Nutrients"},{"issue":"7","key":"4494_CR29","doi-asserted-by":"publisher","first-page":"G775","DOI":"10.1152\/ajpgi.00155.2012","volume":"303","author":"M Camilleri","year":"2012","unstructured":"Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303(7):G775\u201385.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"4494_CR30","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/gutjnl-2022-328515","volume":"72","author":"M Camilleri","year":"2023","unstructured":"Camilleri M, Boeckxstaens G. Irritable bowel syndrome: treatment based on pathophysiology and biomarkers. Gut. 2023;72(3):590\u20139.","journal-title":"Gut"},{"issue":"7","key":"4494_CR31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","volume":"70","author":"DH Vasant","year":"2021","unstructured":"Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, et al. British society of gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214\u201340.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04494-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04494-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04494-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:46:05Z","timestamp":1769514365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-025-04494-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4494"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04494-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6138161\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves human participants and was approved by the Ethical Committee Research UZ\/KU Leuven (S59482). Participants gave informed consent to participate in the study before taking part. All study procedures were performed in accordance to the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JT has given Scientific advice to AlfaWassermann, Allergan, Christian Hansen, Danone, Gr\u00fcnenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand and Zeria pharmaceuticals, has received research support from Shire, Sofar and Tsumura, and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion and Zeria. Funding was provided by a Methusalem grant from Leuven University to JTThis study was supported by a research grant from the Belgian Health Care Knowledge Centre (KCE).Questionnaires in this trial were provided by the Rome Foundation research Institute.\u00a0This study was supported by a research grant from the Belgian Health Care Knowledge Centre (KCE).\u00a0Questionnaires in this trial were provided by the Rome Foundation research Institute.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}